Venture&Growth
Location
Wayne (PA), USA
Venture&Growth
All Portfolio items
See full Venture&Growth portfolio
US-based MedTech company developing a novel venous stent.
Vesper Medical is a medical device company dedicated to the development of a novel venous stent for the treatment of a variety of venous diseases. The company had achieved CE Mark and has initiated the VIVID trial in the US for FDA approval. Vesper was founded in 2016 as a spin-out of Intact Vascular.
In 2022, Royal Philips acquired 100% of the Vesper shares, providing Gilde with an attractive return within a three-year holding period.
More Vesper Medical news
Vesper Medical Announces First Enrollment in the VIVID Trial
Gilde Healthcare co-leads $37M financing of Vesper Medical to complete development of its Duo Venous Stent System
Levicept
UK-based Therapeutics company developing a novel therapy to treat chronic pain.
Shoulder Innovations
Shoulder Innovations is a medical device company that is commercializing a novel shoulder arthroplasty portfolio...
SynOx Therapeutics
SynOx Therapeutics Limited is a Dublin-based, late clinical-stage biopharmaceutical company developing emactuzumab, a best-in-class monoclonal...
